# Clinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery Disease

Study · id `cardio:ct-nct01294748` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01294748](<https://clinicaltrials.gov/study/NCT01294748>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01294748

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 184 participants.

## Technical summary

Registry record NCT01294748. Randomized; single masking; primary purpose treatment. Start 2011-02 (registry gives no type); primary completion 2012-06 (actual). Results posted on 2014-03-26.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 184 participants (enrolled count; ClinicalTrials.gov record NCT01294748, source copy `cardio:ctgov-nct01294748-2017-02-08`, retrieved 2026-10-26)
- Start date: 2011-02 (registry gives no type) (ClinicalTrials.gov record NCT01294748, source copy `cardio:ctgov-nct01294748-2017-02-08`, retrieved 2026-10-26)
- Primary completion: 2012-06 (actual) (ClinicalTrials.gov record NCT01294748, source copy `cardio:ctgov-nct01294748-2017-02-08`, retrieved 2026-10-26)
- Completion: 2016-08 (actual) (ClinicalTrials.gov record NCT01294748, source copy `cardio:ctgov-nct01294748-2017-02-08`, retrieved 2026-10-26)
- Results first posted: 2014-03-26 (ClinicalTrials.gov record NCT01294748, source copy `cardio:ctgov-nct01294748-2017-02-08`, retrieved 2026-10-26)
- Countries: Belgium; France; Netherlands; New Zealand; Sweden; United Kingdom (ClinicalTrials.gov record NCT01294748, source copy `cardio:ctgov-nct01294748-2017-02-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01294748-2017-02-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery Disease
- Acronym: DESSOLVE-II
- Condition: Coronary Artery Disease
- Intervention (Device): MiStent DES
- Intervention (Device): Endeavor DES
- Lead sponsor: Micell Technologies
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Micell Technologies (`cardio:org-micell-technologies`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Randomised study of a bioabsorbable polymer-coated sirolimus-eluting stent: results of the DESSOLVE II trial (`cardio:pubmed-24801119`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Bioabsorbable polymer-coated sirolimus-eluting stent implantation preserves coronary vasomotion: A DESSOLVE II trial sub-study (`cardio:pubmed-25044635`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: dd51327c0b311b88b0e3b5d3d9857b00db2febcb9b4c757503ac77ef1475971f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
